TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
viva text & pharma AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
81
|
53
|
64 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
2
|
6
|
-3 |
| EBITDA |
2
|
-17
|
-9 |
| Total assets |
61
|
59
|
85 |
| Current assets |
61
|
59
|
85 |
| Current liabilities |
11
|
11
|
19 |
| Equity capital |
50
|
48
|
65 |
| - share capital |
5
|
4
|
5 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
82.0%
|
81.4%
|
76.5% |
| Turnover per employee |
81
|
53
|
64 |
| Profit as a percentage of turnover |
2.5%
|
11.3%
|
-4.7% |
| Return on assets (ROA) |
3.3%
|
10.2%
|
-3.5% |
| Current ratio |
554.5%
|
536.4%
|
447.4% |
| Return on equity (ROE) |
4.0%
|
12.5%
|
-4.6% |
| Change turnover |
28
|
-6
|
-15 |
| Change turnover % |
53%
|
-10%
|
-19% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.